drugset / Trial / NCT01519414
Tivantinib in Treating Patients With Metastatic Prostate Cancer
RandomizedCrossoverDouble-blindTreatment
Summary
This randomized phase II trial studies how well tivantinib works compared to placebo in treating patients with metastatic prostate cancer. Tivantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2012-01-11
- Primary completion
- 2015-08-18
- Completion
- 2015-08-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tivantinib | Small molecule | — | Oral |